UB Paderborn / Katalog / Suche / in CDI

Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates

Brain (London, England : 1878), 2020-05, Vol.143 (5), p.1462-1475

2020

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological Analysis Demonstrates Dramatic Alteration of D1 Dopamine Receptor Neuronal Distribution in the Rat Analog of L-DOPA-Induced Dyskinesia

The Journal of neuroscience, 2009-04, Vol.29 (15), p.4829-4835

2009

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological Analysis Demonstrates Dramatic Alteration of D 1 Dopamine Receptor Neuronal Distribution in the Rat Analog of l-DOPA-Induced Dyskinesia

The Journal of neuroscience, 2009-04, Vol.29 (15), p.4829-4835

2009

Link zum Volltext

Verfügbarkeit prüfen

Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia

Movement disorders, 2013-07, Vol.28 (8), p.1088-1096

2013

Link zum Volltext

Verfügbarkeit prüfen

PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking

The Journal of clinical investigation, 2012-11, Vol.122 (11), p.3977-3989

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of blood flow as a route for propagation in experimental synucleinopathy

Neurobiology of disease, 2021-03, Vol.150, p.105255-105255, Article 105255

2021

Link zum Volltext

Verfügbarkeit prüfen

Immediate-early gene expression in structures outside the basal ganglia is associated to l -DOPA-induced dyskinesia

Neurobiology of disease, 2014-02, Vol.62, p.179-192

2014

Link zum Volltext

Verfügbarkeit prüfen

Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate

PloS one, 2010-10, Vol.5 (10), p.e13306-e13306

2010

Link zum Volltext

Verfügbarkeit prüfen

Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism

Movement disorders, 2018-10, Vol.33 (10), p.1632-1642

2018

Link zum Volltext

Verfügbarkeit prüfen

Preclinical development of gene therapy for Parkinson's disease

Experimental neurology, 2008-01, Vol.209 (1), p.72-81

2008

Link zum Volltext

Verfügbarkeit prüfen

Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression

Acta neuropathologica communications, 2015-07, Vol.3 (1), p.46, Article 46

2015

Link zum Volltext

Verfügbarkeit prüfen

Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia

Neuroscience research, 2013-12, Vol.77 (4), p.242-246

2013

Link zum Volltext

Verfügbarkeit prüfen

RGS9 2 Negatively Modulates L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia in Experimental Parkinson's Disease

The Journal of neuroscience, 2007-12, Vol.27 (52), p.14338-14348

2007

Link zum Volltext

Verfügbarkeit prüfen

Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain

NPJ Parkinson's Disease, 2023-09, Vol.9 (1), p.135-135, Article 135

2023

Link zum Volltext

Verfügbarkeit prüfen

Microdialysis in awake macaque monkeys for central nervous system pharmacokinetics

Animal models and experimental medicine, 2018-12, Vol.1 (4), p.314-321

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the expression and toxicity of AAV2/9 carrying the human A53T α-synuclein gene in presence or absence of WPRE

Heliyon, 2021-02, Vol.7 (2), p.e06302-e06302, Article e06302

2021

Link zum Volltext

Verfügbarkeit prüfen

Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens

Journal of neurochemistry, 2005-07, Vol.94 (1), p.140-149

2005

Link zum Volltext

Verfügbarkeit prüfen

Modeling Parkinson's disease in primates: The MPTP model

Cold Spring Harbor perspectives in medicine, 2012-03, Vol.2 (3), p.a009308-a009308

2012

Link zum Volltext

Verfügbarkeit prüfen

Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology

Brain (London, England : 1878), 2022-04, Vol.145 (3), p.1001-1017

2022

Link zum Volltext

Verfügbarkeit prüfen

L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum

Scientific reports, 2014-01, Vol.4 (1), p.3730, Article 3730

2014

Link zum Volltext

Verfügbarkeit prüfen

Acute Striato-Cortical Synchronization Induces Focal Motor Seizures in Primates

Cerebral cortex (New York, N.Y. 1991), 2020-11, Vol.30 (12), p.6469-6480

2020

Link zum Volltext

Verfügbarkeit prüfen

Adenosine A2AR/A1R Antagonists Enabling Additional H3R Antagonism for the Treatment of Parkinson’s Disease

Journal of medicinal chemistry, 2021-06, Vol.64 (12), p.8246-8262

2021

Link zum Volltext

Verfügbarkeit prüfen

Adenosine A 2A R/A 1 R Antagonists Enabling Additional H 3 R Antagonism for the Treatment of Parkinson's Disease

Journal of medicinal chemistry, 2021-06, Vol.64 (12), p.8246-8262

2021

Link zum Volltext

Verfügbarkeit prüfen

Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease

Science translational medicine, 2010-04, Vol.2 (28), p.28ra28

2010

Link zum Volltext

Verfügbarkeit prüfen

Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum

The European journal of neuroscience, 2003-02, Vol.17 (4), p.771-781

2003

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates

Pharmacological Analysis Demonstrates Dramatic Alteration of D1 Dopamine Receptor Neuronal Distribution in the Rat Analog of L-DOPA-Induced Dyskinesia

Pharmacological Analysis Demonstrates Dramatic Alteration of D 1 Dopamine Receptor Neuronal Distribution in the Rat Analog of l-DOPA-Induced Dyskinesia

Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia

PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking

Evaluation of blood flow as a route for propagation in experimental synucleinopathy

Immediate-early gene expression in structures outside the basal ganglia is associated to l -DOPA-induced dyskinesia

Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate

Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism

Preclinical development of gene therapy for Parkinson's disease

Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression

Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia

RGS9 2 Negatively Modulates L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia in Experimental Parkinson's Disease

Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain

Microdialysis in awake macaque monkeys for central nervous system pharmacokinetics

Comparison of the expression and toxicity of AAV2/9 carrying the human A53T α-synuclein gene in presence or absence of WPRE

Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens

Modeling Parkinson's disease in primates: The MPTP model

Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology

L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum

Acute Striato-Cortical Synchronization Induces Focal Motor Seizures in Primates

Adenosine A2AR/A1R Antagonists Enabling Additional H3R Antagonism for the Treatment of Parkinson’s Disease

Adenosine A 2A R/A 1 R Antagonists Enabling Additional H 3 R Antagonism for the Treatment of Parkinson's Disease

Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease

Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum

Suchergebnisse filtern